Technion Israel Institute of Technology
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Technion Israel Institute of Technology
Start-Up Quarterly Statistics: Private And Public Firms Were Prolific Fundraisers
A review of biopharma start-up dealmaking and financing activity from April through June 2017, based on data from Strategic Transactions, showed that fundraising activity more than doubled compared with the first quarter.
Venture Funding Deals: $688.8m In Financings From Avitide To Zai Lab
June venture capital financings for emerging companies totaled more than $688.8m, ranging from an undisclosed round for Avitide to a $120m Series B for Rubius Therapeutics.
Deals Shaping The Medical Industry, July 2017
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in June 2017.
Start-Up Spotlight: Hemonitor, Continuous Bloodflow Monitoring With Ultrasound
Israeli start-up Hemonitor Medical is hoping to make waves with a new hemodynamic monitor that uses an ultrasound patch technology to continuously monitor blood flow in ICU patients or patients in surgery. The company is the first start-up to be taken in by MindUP, Israel's first digital health incubator and a joint partnership between Medtronic, IBM, Pitango Venture Capital, Rambam Hospital and the Impact First investment fund.
- Academic and Research Institutions
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.